pubmed-article:20584554 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20584554 | lifeskim:mentions | umls-concept:C0025914 | lld:lifeskim |
pubmed-article:20584554 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:20584554 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:20584554 | lifeskim:mentions | umls-concept:C0022202 | lld:lifeskim |
pubmed-article:20584554 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
pubmed-article:20584554 | pubmed:issue | 1-2 | lld:pubmed |
pubmed-article:20584554 | pubmed:dateCreated | 2010-9-10 | lld:pubmed |
pubmed-article:20584554 | pubmed:abstractText | The association between anti-triosephosphate isomerase (TPI) antibodies and MRL/MpJ-Fas(lpr) (MRL/lpr) mice was examined. We found that serum anti-TPI antibody levels in MRL/lpr mice, measured by enzyme-linked immunosorbent assay, were significantly higher than that of age-matched Balb/c mice and NZB/WF1 mice. Anti-TPI antibodies were detected in serum and cerebrospinal fluid in MRL/lpr mice by Western blotting. Inoculation of anti-TPI monoclonal antibody-producing hybridoma into the brain of Balb/c mice resulted in immunoglobulin deposition in the regions near the ventricles, hippocampus, and choroid plexus. Anti-TPI antibodies may play a role in the etiology of brain damage and behavioral deficits in MRL/lpr mice. | lld:pubmed |
pubmed-article:20584554 | pubmed:language | eng | lld:pubmed |
pubmed-article:20584554 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20584554 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20584554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20584554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20584554 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20584554 | pubmed:month | Sep | lld:pubmed |
pubmed-article:20584554 | pubmed:issn | 1872-8421 | lld:pubmed |
pubmed-article:20584554 | pubmed:author | pubmed-author:WatanabeHiros... | lld:pubmed |
pubmed-article:20584554 | pubmed:author | pubmed-author:SatoShuzoS | lld:pubmed |
pubmed-article:20584554 | pubmed:author | pubmed-author:KobayashiHiro... | lld:pubmed |
pubmed-article:20584554 | pubmed:author | pubmed-author:OhiraHiromasa... | lld:pubmed |
pubmed-article:20584554 | pubmed:author | pubmed-author:ShioKioriK | lld:pubmed |
pubmed-article:20584554 | pubmed:copyrightInfo | Copyright © 2010 Elsevier B.V. All rights reserved. | lld:pubmed |
pubmed-article:20584554 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20584554 | pubmed:day | 14 | lld:pubmed |
pubmed-article:20584554 | pubmed:volume | 226 | lld:pubmed |
pubmed-article:20584554 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20584554 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20584554 | pubmed:pagination | 110-5 | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:meshHeading | pubmed-meshheading:20584554... | lld:pubmed |
pubmed-article:20584554 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20584554 | pubmed:articleTitle | Association of anti-triosephosphate isomerase antibody and MRL/MpJ-Faslpr mouse. | lld:pubmed |
pubmed-article:20584554 | pubmed:affiliation | Fukushima Medical University, Department of Gastroenterology and Rheumatology, School of Medicine, 1 Hikarigaoka, Fukushima 960-1295, Japan. | lld:pubmed |
pubmed-article:20584554 | pubmed:publicationType | Journal Article | lld:pubmed |